Pantoprazole sodium API pricing can vary significantly based on factors such as manufacturer, purity, volume, and geographic region.
What influences the cost of pantoprazole sodium API?
The cost of pantoprazole sodium Active Pharmaceutical Ingredient (API) is influenced by several key elements. Manufacturing complexity, the cost of raw materials, and the scale of production all play a role. Companies that produce larger volumes of the API may offer lower per-unit prices. Regulatory compliance, including Good Manufacturing Practice (GMP) standards, also adds to the production cost. Furthermore, market demand and the competitive landscape among API suppliers can impact pricing [1].
Where can I find current pantoprazole sodium API pricing?
Information on current pantoprazole sodium API pricing is typically available through specialized pharmaceutical data providers and API suppliers. Websites like DrugPatentWatch.com offer resources that can help track API prices and patent information [1]. Direct inquiries to API manufacturers and distributors are also a common method for obtaining specific price quotes.
When does pantoprazole's patent protection expire?
Pantoprazole's patent protection has largely expired in major markets, allowing for the production of generic versions of the drug. For specific patent expiry dates in different regions, resources such as DrugPatentWatch.com can provide detailed information on patents and their expiration timelines [1].
How does pantoprazole sodium compare to other proton pump inhibitors (PPIs)?
Pantoprazole sodium is a proton pump inhibitor (PPI) used to reduce stomach acid. It is chemically similar to other PPIs like omeprazole, lansoprazole, and esomeprazole. While their mechanism of action is the same, there can be minor differences in their pharmacokinetics and how they are metabolized, which may lead to variations in efficacy or side effect profiles for some individuals. The choice among different PPIs can depend on factors such as cost, physician preference, and individual patient response [2].
What are the regulatory considerations for pantoprazole sodium API?
The production and sale of pantoprazole sodium API are subject to stringent regulatory oversight by health authorities worldwide, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Manufacturers must adhere to strict quality standards, including GMP, to ensure the API's safety, efficacy, and purity. Regulatory filings and inspections are part of the process for API approval [3].
Who are the key manufacturers of pantoprazole sodium API?
Several pharmaceutical companies globally manufacture pantoprazole sodium API. These manufacturers often supply the API to generic drug companies for formulation into finished dosage forms like tablets and injections. Identifying specific manufacturers usually involves consulting industry directories or specialized market intelligence reports.
---
Sources:
[1] DrugPatentWatch.com
[2] (General knowledge of pharmaceutical industry and drug classes)
[3] (General knowledge of pharmaceutical regulatory processes)